Search

Author/Creator Welting, O

1. A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function. Issue 4 (14th March 2019)

Authors:
De Vries, L C S; Duarte, J M; De Krijger, M; Welting, O; Van Hamersveld, P H P; Van Leeuwen-Hilbers, F W M; Moerland, P D; Jongejan, A; D'Haens, G R; De Jonge, W J; Wildenberg, M E
Journal:
Inflammatory bowel diseases
Issue:
Volume 25:Issue 4(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function. Issue 4 (19th January 2019)

Authors:
De Vries, L C S; Duarte, J M; De Krijger, M; Welting, O; Van Hamersveld, P H P; Van Leeuwen-Hilbers, F W M; Moerland, P D; Jongejan, A; D'Haens, G R; De Jonge, W J; Wildenberg, M E
Journal:
Inflammatory bowel diseases
Issue:
Volume 25:Issue 4(2019)
Page Start:
647
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗